Pennsylvania-based Ocugen just signed an agreement giving in the rights to the Bharat Biotech Covid-19 vaccine candidate, Covaxin, in the United States. Ocugen will be responsible for clinical development, regulatory approval (including Emergency Use Authorization) and commercialization of this Indian vaccine in America. Covaxin is an advanced stage whole-virion inactivated...